Fig. 7From: Theranostic RGD@Fe3O4-Au/Gd NPs for the targeted radiotherapy and MR imaging of breast cancerChanges in the survival rate of MDA-MB-231 cells in X-ray treatment of 6 MeV at the dose of 2 Gy and a dose of 200 C/min in the presence Fe3O4-Au/Gd@RGD, Fe3O4-Au/Gd and absence of NPs (*significant difference with the control group, **significant difference of NPs with and without peptide at a specific concentration P-value < 0.05)Back to article page